MaderJT (chairman), Scientific Committee. Hyperbaric oxygen therapy-a committee report. Bethesda MD: Undersea and Hyperbaric Medical Society, 1989.
2.
Hyperbaric oxygen therapy-covered conditions. Medicare carrier's manual, coverage issues appendix. Washington DC: Health Care Finance Administration (HCFA), September1984.
3.
Henshaw. In: SimpsonA, ed. Compressed air as a therapeutic agent in the treatment of consumption, asthma, chronic bronchitis, and other diseases. Edinburgh, Scotland: Sutherland & Know, 1857.
4.
BrummelkampWH, HogendijkJ, BoeremaJ.Treatment of anaerobic infections (clostridial myositis) by drenching the tissues with oxygen under high atmospheric pressure. Surgery1961;49:299–302.
5.
BoeremaI, MeijneNG, BrummelkampWH, BrownmaS, MenschMH, KamermansF, . Life without blood: a study of the influence of high atmospheric pressure and hypothermia on dilution of blood. J Cardiovasc Surg1960;1:133–146.
6.
TrimbleVH. The uncertain miracle. Garden City NY: Doubleday & Co Inc, 1974.
7.
BatzPG, MyersRAM. Hyperbaric chambers-United States and Canada. Bethesda MD: Undersea and Hyperbaric Medical Society, 1990.
8.
KindwallEP, GoldmannRW. Hyperbaric medicine procedures. Milwaukee WI: St Luke's Medical Center, 1988.
9.
HamiltonRW. Monoplace and multiplace HBO cham-bers: the roles of each. In: HamiltonRW, PierceECII, eds. Hyperbaric oxygen in emergency medical care. Bethesda MD: Undersea Medical Society, 1983:91–101.
10.
MyersRA. Functional hyperbaric chamber facilities. Baltimore MD: Maryland Institute of Emergency Medical Services (MIEMSS), January, 1988.
11.
DavisJC (chairman). Workshop report on treatment of serious decompression sickness and arterial gas embo-lism. Bethesda MD: Undersea Medical Society, 1979:77–78.
12.
WeaverLK. Clinical applications of hyperbaric oxygen-monoplace chamber use. In: MoonRH, CamporesiEM, eds. Problems in respiratory care-clinical application of hyperbaric oxygen. Philadelphia: JB Lippincott, 1991;4(2):189–214.
13.
WeaverLK, StraussMB, eds. Monoplace hyperbaric chamber safety guidelines. Bethesda MD: Undersea and Hyperbaric Medical Society, 1991:31–48.
14.
HolcombJR, Matos-NavarroAY, GoldmannRW. Crit-ical care in the hyperbaric chamber. In: DavisJC, HuntTK, eds. Problem wounds: the role of oxygen. New York: Elsevier, 1988:187–209.
15.
WeaverLK. Pulmonary artery catheter use in critically ill patients treated in the monoplace hyperbaric chamber (abstract). Undersea Biomed Res1990;17(Suppl):132.
16.
HartGB, ShandlingAH, EllestadMH. Hyperbaric oxy-gen (HBO) and thrombolysis in myocardial infarction: a preliminary report (abstract). Undersea Biomed Res1990;17(Suppl):65.
17.
KindwallEP, GoldmannRW, ThombsPA. Use of the monoplace vs multiplace chamber in the treatment of diving diseases. J Hyperbaric Med1988;3(1):5–10.
18.
HartGB, StraussMB, LennonPA. The treatment of decompression sickness and air embolism in a mono-place chamber. J Hyperbaric Med1986;1(1):1–7.
19.
WeaverLK. Monoplace chamber use of U.S. Navy Treatment Table 6 to treat decompression sickness and arterial gas embolism (abstract). Undersea Biomed Res1988;15(Suppl):63.
20.
MoonRH. Monoplace chamber use in the treatment of diving accidents (editorial). J Hyperbaric Med1988;3(1):1–3.
21.
BlanchPB, DesautelsDA, GallagherTJ. Deviations in function of mechanical ventilators during hyperbaric compression. Respir Care1991;36:803–814.
22.
WeaverLK, GreenwayL, ElliottCG. Performance characteristics of the Sechrist 500A hyperbaric ven-tilator in a monoplace hyperbaric chamber. J Hyperbaric Med1988;3(4):215–225.
23.
MoonRH, BerquistLV, ConklinB, MillerJN. Mon-aghan 225 ventilator use under hyperbaric conditions. Chest1986;89(6):846–851.
24.
ClarkJM. Oxygen toxicity. In: BennettPB, ElliottDH, eds. The physiology and medicine of diving, 3rd ed. London: Bailliere, Tindall & Cox, 1982:229–233.
25.
ClarkJM, LambertsonCJ. Alveolar-arterial O2 differ-ences in man at 0.2, 1.0, 2.0, and 3.5 Ata inspired PO2. J Appl Physiol1971;30(5):753–763.
26.
MoonRE, CamporesiEM, SheltonDL. Prediction of arterial PO2 during hyperbaric treatments. In: BoveAA, BachrachAJ, GreenbaumLJJr, eds. Proceedings of the 9th International Symposium on Underwater and Hyper-baric Physiology. Bethesda MD: Undersea and Hyperbaric Medical Society, 1987:1125–1131.
27.
WellsCH, GoodpastureJE, HorriganDJ, HartGB. Tissue gas measurements during hyperbaric oxygen expo-sure. In: SmithG, ed. Proceedings of the 6th Inter-national Congress on Hyperbaric Medicine. Aberdeen, Scotland: Aberdeen University Press, 1977:118–124.
28.
Oxygen/air treatment of unresolved or worsening symp-toms of decompression sickness or arterial gas embo-lism. In: Navy Department. U.S. Navy diving manual (NAVSEA) 0994-LP-001-9010, Vol. 1. Department of the Navy. Washington DC: Government Printing Office, 1985;8:39.
29.
LanphierEH, BrownIWJr. The physiological basis of hyperbaric therapy. In: SeeleySF, ed. Fundamentals of hyperbaric medicine, by the Committee on Hyperbaric Oxygenation (publication 1298). Washington DC: National Academy of Sciences, National Research Council, 1966:33–55.
30.
WeaverLK, HoweSH. Arterial oxygen tension of patients with abnormal pulmonary function during hyperbaric oxygen therapy (abstract). Undersea Biomed Res1991;18(Suppl):107–108.
31.
WeaverLK, HoweS, BerlinSL. Normobaric measure-ment of oxygen tension of blood and saline tonometered under hyperbaric oxygen conditions. J Hyperbaric Med1990;5(1):29–38.
32.
BabiorBM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med1974;298:659–668.
33.
Van UnnikAJM. Inhibition of toxin production in Clos-tridium perfringes in vitro by hyperbaric oxygen. Antonie Van Leeuwenhoek1965;31:181–186.
34.
HillGB, OsterhoutS.Experimental effects of hyper-baric oxygen on selected clostridial species: I. In vitro studies. J Infect Dis1972;125:17–25.
35.
DavisJC, ElliottDH. Treatment of decompression dis-orders. In: BennettPB, ElliottDH, eds. The physiology and medicine of diving, 3rd ed. London: Bailliere, Tin-dall & Cox, 1982:473–487.
36.
HickamJB, FrayserR, RossJC. A study of retinal venous blood oxygen saturation in human subjects by photographic means. Circulation1963;27:375–385.
37.
BirdAD, TelferABM. Effect of hyperbaric oxygen on limb circulation. Lancet1965;1:355–356.
38.
NylanderG, NordstromH, EricksonE.Effects of hyper-baric oxygen on oedema formation after a scald burn. Burns1984;10:193–196.
39.
NylanderG, LewisD, NordstromH, LarssonJ.Reduc-tion of post-ischemic edema with hyperbaric oxygen. Plast Reconstr Surg1985;76(4):596–601.
40.
StraussMB, HargensAR, GershuniDH, GreenbergDA, CrenshawAG, HartGB, . Reduction of skel-etal muscle necrosis using intermittent hyperbaric oxy-gen in a model compartment syndrome. J Bone Joint Surg [AM]1983;65-A(5):656–662.
41.
SilverIA. Local and systemic factors which affect the proliferation of fibroblasts. In: KulonenE, PikkarainenJ, eds. The biology of fibroblast. Orlando FL: Academic Press Inc, 1973:507–520.
42.
HuntTK, PaiMP. The effect of varying ambient oxy-gen tensions on wound metabolism and collagen syn-thesis. Surg Gynecol Obstet1972;135:561–567.
43.
MarxRE, EhlerEJ, TayapongsakP, PierceLW. Rela-tionship of oxygen to angiogenesis induction in irradi-ated tissue. Am J Surg1990;160:519–524.
44.
MarxRE, JohnsonRP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol1987;64(4):379–390.
45.
MarxRE, JohnsonRP, KlineSN. Prevention of osteo-radionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc1985;111:49–54.
46.
MarxRE, JohnsonRP. Problem wounds in oral and maxillofacial surgery: the role of hyperbaric oxygen. In: DavisJC, HuntTK, eds. Problem wounds: the role of oxygen. New York: Elsevier, 1988:65–124.
47.
VerklinRMJr, MandellGL. Alteration of effectiveness of antibiotics by anaerobiosis. J Lab Clin Med1977;89:65–71.
48.
MathiewD, CogetJ, VinckierL, . Red blood cell deformability and hyperbaric oxygen. Medecine Sub-aquatie et Hyperbare1984;3:100–104. (English trans-lation available from U.S. Air Force, Technical Services Division, School of Aerospace Medicine, Brooks AFB, Texas).
49.
BondGF. Arterial gas embolism. In: DavisJC, HuntTK, eds. Hyperbaric oxygen therapy. Bethesda MD: Undersea Medical Society, 1977:141–152.
50.
KindwallEP. Massive surgical embolism treated with brief recompression to six atmospheres followed by hyperbaric oxygen. Aerospace Med1973;44:663–666.
51.
MurphyBP, HarfoldFJ, CramerFS. Cerebral air embo-lism resulting from invasive medical procedures: treat-ment with hyperbaric oxygen. Ann Surg1985;201(2):242–245.
52.
BaskinFE, WozniakRL. Hyperbaric oxygenation in the treatment of hemodialysis-associated air embolism. N Engl J Med1975;293(4):184–185.
53.
MariniJJ, CulverBH. Systemic gas embolism com-plicating mechanical ventilation in the adult respiratory distress syndrome. Ann Intern Med1990;110:699–703.
54.
CalesRH, HumphreysN, PilmanisAA, HeiligRW. Cardiac arrest from gas embolism in scuba diving. Ann Emerg Med1981;10:589–592.
55.
Ah-SeeAK. Review of the arterial air embolism in sub-marine escape. In: SmithG, ed. Proceedings of the 6th Congress on Hyperbaric Medicine. Aberdeen, Scotland: Aberdeen University Press, 1979:349–351.
56.
ArmonC, DeschampsC, AdkinsonC, FealeyRD, Ors-zulakTA. Hyperbaric treatment of cerebral air embo-lism sustained during an open-heart surgical procedure. Mayo Clin Proc1991;66:565–571.
57.
LaytonAJ. Hyperbaric oxygen treatment for cerebral air embolism-where are the data? (editorial). Mayo Clin Proc1991;66:641–646.
58.
PierceECII. Cerebral gas embolism (arterial) with spe-cial reference to iatrogenic accidents. HBO Rev1980;1(3):161–184.
59.
MaderJT, HuletWH. Delayed hyperbaric treatment of cerebral air embolism. Arch Neurol1979;36:504–505.
60.
DovenbargerJA (coordinator). 1989 report on diving accidents and fatalities. Durham NC: Divers' Alert Net-work, 1991.
61.
WeienRW, BaumgartnerN.Altitude decompression sickness: hyperbaric therapy results in 528 cases. Aviat Space Environ Med1990;61:833–836.
62.
VannRD. Decompression theory and applications. In: BennettPB, ElliottPH, eds. The physiology and med-icine of diving, 3rd ed. London: Bailliere, Tindall & Cox, 1982:352–382.
63.
WardCA, McCulloughD, YeeD, StangaD, FraserWD. Complement activation involvement in decom-pression sickness of rabbits. Undersea Biomed Res1990;17:51–66.
64.
McCallumRI, HarrisonJAB. Dysbaric osteonecrosis: aseptic necrosis of bone. In: BennettPB, ElliottDH, eds. The physiology and medicine of diving, 3rd ed. London: Bailliere, Tindall & Cox, 1982:488–506.
65.
CobbN, EtzelRA. Unintentional carbon monoxide-related deaths in the United States, 1979 through 1988. JAMA1991;266(5):659–663.
66.
StewartRD, FisherTN, HoskoMJ, PetersonJE, BarettaED, DoddHC. Carboxyhemoglobin elevation after exposure to dichloromethane. Science1972;176:295–296.
67.
BernardC.Lecons sur effects des substances toxiques et medicamenteuses. Paris: Bailliere et Fils, 1857. Quoted in: Piantadosi CA. Carbon monoxide, oxygen transport, and oxygen metabolism. J Hyperbaric Med 1987;2(1): 27-44.
68.
HaldaneJS. The relationship of the action of carbonic oxide to oxygen tension. J Physiol (Lond)1895;18:201–217.
69.
RoughtonFJW, DarlingRC. The effect of carbon mon-oxide on the oxyhemoglobin dissociation curve. Am J Physiol1944;141:17–31.
70.
CoburnRF. Mechanisms of carbon monoxide toxicity. Prev Med1979;8:310–322.
71.
PaceN, StrajmanE, WalkerEL. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science1950;111:652–654.
72.
PetersonJE, StewartRD. Absorption and elimination of carbon monoxide by inactive young men. Arch Environ Health1970;21:165–171.
73.
SluyterME. The treatment of carbon monoxide by administration of oxygen at high atmospheric pressure. Proc R Soc Med1963;56:1002.
74.
MyersRA, SnyderS, EmhoffTA. Subacute sequelae of carbon monoxide poisoning. Ann Emerg Med1985;14:1163–1167.
KeilinD, HartreeEF. Cytochrome and cytochrome oxi-dase. Proc R Soc Lond [Biol]1939;127:167–191.
77.
PiantadosiCA, SylviaAL, SaltzmanHA, Jobsis-Vander VlietFF. Carbon monoxide-cytochrome interactions in the brain of the fluorocarbon-perfused rat. J Appl Phys-iol1985;58:665–672.
78.
FormanHJ, FeigelsonP.Kinetic evidence indicating the absence during catalysis of an unbound ferro-proto-porphyrin form of tryptophan oxidase. Biochemistry1971;10:760–763.
79.
CoburnRF, MayersLB. Myoglobin oxygen tension determined from measurements of carboxymyoglobin in skeletal muscle. Am J Physiol1971;220:66–74.
80.
ThomSR. Carbon monoxide-mediated brain lipid per-oxidation in the rat. J Appl Physiol1990;68:997–1003.
81.
ThomSR. Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol Appl Pharm1990;105:340–344.
82.
RaphaelJC, ElkharratD, Jars-GuincestreMC, ChastangC, ChaslesV, VerckenJB, . Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet1989;2:414–419.
83.
DucasseJL, IzardPH, CelsisP, LeclercqC, Marc-VergnesJP, CathalaB.Moderate carbon monoxide poi-soning: hyperbaric or normobaric oxygenation? In: Bak-kerDJ, SchmutzJ, eds. Proceedings of the 2nd Swiss Symposium on Hyperbaric Medicine. Basel, Switzer-land: Foundation for Hyperbaric Medicine, 1990:289–297.
84.
MyersRAM, MessierLD. The development of a neuro-psychological screening battery for use in the clinical assessment of carbon monoxide-intoxicated patients. In: KindwallEP, ed. Proceedings of the 8th International Congress on Hyperbaric Medicine. San Pedro CA: Best Publishing, 1987:258–262.
85.
GoulonM, BaroisA, RapinM, NouailhatF, GrosbuisS, LabrousseJ.Carbon monoxide poisoning and acute anoxia due to breathing coal gas and hydrocarbons. J Hyperbaric Med1986;1(1):23–41.
86.
Sponenburg v. County of Wayne, 308 N.W. 2d 589 (Mich App. 1981).
87.
RoyTM, MendietaJM, OssorioMA, WoulkerJF. Per-ceptions and utilization of hyperbaric oxygen therapy for carbon monoxide poisoning in an academic setting. J Kentucky Med Assoc1989;87:223–226.
88.
KindwallEP. Hyperbaric treatment of carbon monoxide poisoning (editorial). Ann Emerg Med1985;14:1233–1234.
89.
GabbG, RobinED. Hyperbaric oxygen-a therapy in search of diseases. Chest1987;92(6):1074–1082.
90.
HeimbachDM, WaeckerleJF. Inhalation injuries. Ann Emerg Med1988;17(12):1316–1320.
91.
HillRKJr. Gray matters: is it ethical to do a ran-domized study on the use of HBOT in carbon monoxide (CO) poisoning?Pressure1991;206(1):7–8.
92.
ThomSR, KeimLW. Carbon monoxide poisoning: a review of epidemiology, pathophysiology, clinical find-ings, and treatment options including hyperbaric oxygen therapy. Clin Toxicol1989;27:141–156.
93.
WeinsteinL, BragaMA. Current concepts of gas gan-grene. N Engl J Med1972;289:1129–1131.
94.
MacLennanJD. The histotoxic clostridial infections of man. Bacteriol Rev1962;26:177–276.
95.
SwartzMN. Myositis. In: MandellGL, DouglassRG, BennettJE, eds. Principles and practice of infectious diseases. New York: Churchill-Livingstone, 1990:815.
96.
TraubWH. Chemotherapy of experimental (murine) Clostridium perfringens Type A gas gangrene. Chemo-therapy1988;34:472–477.
97.
DemelloFJ, HaglinJJ, HitchcockCR. Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery and hyperbaric oxygen. Surgery1973;73:936–941.
98.
HeimbachRD. Gas gangrene: review and update. HBO Rev1980;1(1):41–46.
99.
BakkerDJ. The use of hyperbaric oxygen in the treat-ment of certain infectious diseases, especially gas gan-grene and acute dermal gangrene. Wageningen (Hol-land): Drukkerij Veenman BV, 1984.
100.
RisemanJA, ZamboniWA, CurtisA, GrahamDR, Kon-radHR, RossDS. Hyperbaric oxygen therapy for necro-tizing fascitis reduces mortality and the need for debridements. Surgery1990;108:847–850.
101.
AhrenholzDH. Surgical spectrum: clinical skin and soft tissue infection. Physicians world communications (monograph). West Point PA: Merck, Sharpe, & Dohme, 1988:16–24.
102.
KnightonDR, HallidayB, HuntTK, GoldstickTK. Oxy-gen as an antibiotic: the effect of inspired oxygen on infection. Arch Surg1984;119:199–204.
103.
MaderJT, AdamsKR, SuttonTE. Infectious diseases: pathophysiology and mechanisms of hyperbaric oxygen. J Hyperbaric Med1987;2:133–140.
104.
MandellG.Bactericidal activity of aerobic and anaer-obic polymorphonuclear neutrophils. Infect Immunol1974;9:337–341.
105.
OnderdonkAB, JohnstonJ, MayhewJW, GorbachSL. Effect of dissolved oxygen and Eh on Bacteroides frag-ilis during continuous culture. Appl Environ Microbiol1976;31:168–172.
106.
MaderJT. Mixed anaerobic and aerobic soft tissue infection. In: DavisJC, HuntTK, eds. Problem wounds: the role of oxygen. New York: Elsevier, 1988:173–186.
SudarskyLA, LaschingerJC, CoppaGF, SpencerFC. Improved results from a standardized approach in treat-ing patients with necrotizing fasciitis. Ann Surg1987;206(5):661–665.
109.
StraussMB, HartGB. Compartment syndromes: role of hyperbaric oxygen. HBO Rev1984;5(3):163–182.
110.
SkyharMJ, HargensAR, StraussMB, GershuniDH, HartGB, AkesonWH. Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. J Bone Joint Surg [AM]1986;68-A(8):1218–1224.
111.
StraussMB, HargensAR, GershuniDH, HartGB, AkesonWH. Delayed use of hyperbaric oxygen for treat-ment of a model anterior compartment syndrome. J Orthopedic Res1986;4(1):108–111.
112.
NemiroffPM. Synergistic effects of pentoxifylline and hyperbaric oxygen on skin flaps. Arch Otolaryngol Head Neck Surg1988;114:977–981.
113.
ChampionWM, McSherryCK, GoulianDJr. Effect of hyperbaric oxygen on the survival of pedicled skin flaps. J Surg Res1967;7:583–586.
114.
NiinikoskiJ.Viability of ischemic skin flaps in hyper-baric oxygen. In: TrappWG, BannisterEW, DavisonAJ, TrappPA, eds. Proceedings of the 5th International Hyperbaric Congress. Burnaby, Canada: Simon Fraser University, 1973;1:244–252.
115.
McFarlaneRM, WermuthRE. The use of hyperbaric oxygen to prevent necrosis in experimental pedicle flaps and composite skin grafts. Plast Reconstr Surg1966;37:422–430.
116.
NemiroffPM, LunguAP. Influence of hyperbaric oxy-gen and irradiation on vascularity in skin flaps: a con-trolled study. Surg Forum1987;38:565–567.
117.
PerrinsDJD, DavisJC. Enhancement of healing in soft tissue wounds. In: DavisJC, HuntTK, eds. Hyperbaric oxygen therapy. Bethesda MD: Undersea Medical Soci-ety, 1978:229–248.
118.
PerrinsDJD. Influence of hyperbaric oxygen on the sur-vival of split skin grafts. Lancet1967;1:868–871.
119.
Moines-ChassI, HashmonaiM.Hyperbaric oxygen treatment as an adjunct to reconstructive vascular sur-gery in trauma. Injury1975;8:274–277.
120.
BowersoxJC, StraussMB, HartGB. Clinical expe-rience with hyperbaric oxygen therapy in the salvage of ischemic skin flaps and grafts. J Hyperbaric Med1986;1(3):141–149.
121.
AllenKD, DanforthJS, DrabmanRS. Videotaped mod-eling and film distraction for fear reduction in adults undergoing hyperbaric oxygen therapy. J Consult Clin Psych1989;57(4):554–558.
122.
BalentineJD. Pathology of oxygen toxicity. Charleston SC: Academic Press, 1982:82–147.
123.
HartGB, StraussMB, PierceECII. The incidence of central nervous system (CNS) oxygen toxicity in a clin-ical setting. In: SmithG, ed. Proceedings of the 6th International Congress on Hyperbaric Medicine. Aber-deen, Scotland: Aberdeen University Press, 1979:47–52.
124.
DavisJC, DunnJM, HeimbachRD. Hyperbaric med-icine: patient selection, treatment procedures, and side-effects. In: DavisJC, HuntTK, eds. Problem wounds: the role of oxygen. New York: Elsevier, 1988:225–235.
125.
BleibergB, KeremD.Central nervous system oxygen toxicity in the resting rat: postponement by intermittent oxygen exposure. Undersea Biomed Res1988;15(5):337–352.
126.
HendricksPL, HallDA, HunterWHJr, HaleyPJ. Extension of pulmonary oxygen tolerance in man at 2 ATA by intermittent oxygen exposure. J Appl Physiol: Respirat Environ Exercise Physiol1977;42:593–599.
127.
LyneAJ. Ocular effects of hyperbaric oxygen. Trans Ophthalmol Soc UK1978;98:66–68.
128.
AndersonBJr, SheltonDL. Axial length in hyperoxic myopia. In: BoveAA, BachrachAJ, GreenbaumLJJr, eds. Underwater and hyperbaric physiology IX. Bethesda MD: Undersea and Hyperbaric Medical Soci-ety, 1987:607–611.
129.
PalmquistBM, PhillipsonB, BarrPO. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol1984;68:113–117.
130.
RockswoldGL, FordE, AndersonJR, BlanchfieldE.Patient monitoring in the monoplace hyperbaric cham-ber. HBO Rev1985;6(3):161–168.
131.
WeaverLK, HoweS.Non-invasive Doppler blood pres-sure monitoring in the monoplace hyperbaric chamber. J Clin Monit1991;7:304–308.
132.
MeyerGW, HartGB, StraussMB. Non-invasive blood pressure monitoring in the hyperbaric monoplace cham-ber. J Hyperbaric Med1990;4(4):211–216.
133.
MoonRE, CamporesiEM. Operational use and patient monitoring in a multiplace hyperbaric chamber. In: MoonRH, CamporesiEM, eds. Problems in respiratory care: clinical application of hyperbaric oxygen. Phil-adelphia: JB Lippincott, 1991;4(2):172–188.
134.
DavisJC, BuckleyCJ, BarrPO. Compromised soft-tissue wounds: correction of wound hypoxia. In: DavisJC, HuntTK, eds. Problem wounds: the role of oxygen. New York: Elsevier, 1988:144–146.
135.
DavisJC. The use of adjunctant hyperbaric oxygen in the treatment of the diabetic foot. Clin Podiatr Med Surg1987;4(2):429–437.
MaderJT, BrownGL, GuckianJC, WellCH, ReinarzJA. A mechanism for the amelioration by hyperbaric oxy-gen of experimental staphylococcal osteomyelitis in rab-bits. J Infect Dis1980;142:915–922.
MaderJT, GuckianJC, GlassDL, ReinarzJA. Therapy with hyperbaric oxygen for experimental osteomyelitis due to staphylococcal aureus in rabbits. J Infect Dis1978;138:312–318.
140.
DavisJC, HeckmanJD, DeLeeJC, BuckwoldFJ. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg [Am]1986;68-A:1210–1217.
CianciP, LuedersH, LeeH, ShapiroR, SextonJ, Wil-liamsC.Adjunctive hyperbaric oxygen reduces the need for surgery in 40-80% burns. J Hyperbaric Med1988;3(2):97–101.